Archive: 19/06/2017
Researchers seek biomarker to assess spinal muscular atrophy treatment
Spinal muscular atrophy (SMA) is the leading genetic cause of death in infants, affecting 1 in 11,000 live births. As promising new therapies such as those directly targeting survivor motor neuron (SMN) are entering clinical ...
Jun 19, 2017
Clinical trial for a better treatment for mycetoma starts in Sudan
The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre (MRC) in Khartoum, Sudan.
Jun 19, 2017